F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart,
following irregularity reporting guidelines in developed policies and procedures.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews and record review the facility failed to act upon the pharmacist's drug regimen review irregularity
reports for two of (Residents #1 and #2) of seven residents reviewed for medication consents.
1. The facility failed to respond to the pharmacist's notification that Resident #1's Trazodone (an
antidepressant and sedative medication used to treat depression and may also be used for other
conditions) consent was missing and needed to be obtained and uploaded. The facility had an unsigned
written consent from Resident #1's RP before administering Trazodone.
2. The facility failed to respond to the pharmacist's notification that Resident #2's Lorazepam (a medication
used to treat anxiety) consent was missing and needed to be obtained and uploaded. The facility had an
unsigned written consent from Resident #2's RP before administering Lorazepam.
This failure could place residents at risk of not having their preferred RP represent them in medical and
care decisions, their preferred RP being unaware of the care, treatment, and treatment alternatives they are
being provided, and not having pharmacist's notifications and recommendations for their medications and
treatments followed.
Findings included:
Resident #1
Review of Resident #1's admission record, dated 09/19/24, reflected a [AGE] year-old female who was
admitted to the facility on [DATE], had a POA/RP , and with diagnoses including burns involving 20-29% of
body surface with 0%-9% third degree burns, bipolar disorder current episode depressed mild or moderate
severity unspecified, generalized anxiety disorder, and cognitive communication deficit.
Review of Resident #1's quarterly MDS, dated [DATE], reflected a BIMS score of 3, indicating she had
severe cognitive impairment. Section N (Medications) reflected Resident #1 was receiving an antipsychotic
and antidepressant.
Review of Resident #1's quarterly care plan, dated 08/19/24, reflected she had a mood problem related to
bipolar disorder, anxiety, and history of alcohol abuse with an intervention to monitor, record, and/or report
to MD as needed any signs or symptoms of depression, anxiety, or sad mood. Resident #1's care plan also
reflected she used antipsychotic medications (Seroquel) related to bipolar disorder with an intervention to
monitor/document/report as needed any adverse reactions of antipsychotic medications, such as insomnia.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675956
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675956
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/19/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Windsor Nursing and Rehabilitation Center of Duval
5301 W Duval Rd
Austin, TX 78727
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of Resident #1's order summary report, dated 09/19/24, reflected an active order started on
06/10/24 for the following: Trazodone HCI Oral Tablet 50 MG (Trazodone HCI) Give 0.5 tablet by mouth at
bedtime for insomnia (give 25mg).
Review of Resident #1's electronic health records, as of 09/19/24, reflected there was no consent form for
her Trazodone HCI Oral Tablet 50 MG (Trazodone HCI) order.
Review of Resident #1's MAR schedule for August and September 2024 reflected she received the
Trazodone order from 08/01/24 through 09/18/24 .
Resident #2
Review of Resident #2's admission record, dated 09/19/24, reflected a [AGE] year-old female who was
admitted to the facility on [DATE], had an RP, and with diagnoses including paranoid schizophrenia and
unspecified dementia.
Review of Resident #2's quarterly MDS, dated [DATE], reflected no BIMS score indicated. Section N
(Medications) reflected Resident #1 was receiving an antidepressant.
Review of Resident #2's quarterly care plan, dated 08/27/24, reflected she had the potential to be verbally
aggressive related to dementia and mental/emotional illness.
Review of Resident #2's order summary report, dated 09/19/24, reflected she completed the following order
started on 08/22/24 and ended on 09/05/24:
Lorazepam (Ativan) 0.5MG/ML GEL 0.5 mg/1ml MG/ML (Lorazepam) Apply 0.5 mg transdermally every 8
hours as needed for anxiety/agitation for 14 Days.
Review of Resident #2's Informed Consent for Psychoactive Medications, undated, reflected an order for
Lorazepam Gel for acute agitation and anxiety. Resident #2 printed her name on the consent 08/22/24 and
did not sign. RP printed their name on 08/22/24 and did not sign. Facility representative who provided
information and completed the consent form signed on 08/22/24 .
Review of Resident #2's MAR schedule for August and September 2024 reflected she did not receive the
Lorazepam order from 08/01/24 through 09/18/24 .
Review of the facility's Pharmacist Review from June through August 2024 reflected the Pharmacist
initiated a medication regimen review on 06/17/24 and indicated Resident #1's Trazodone consent was
unable to be located and recommended staff to obtain and scan consent into the chart. The Pharmacist
also initiated a medication regimen review on 08/26/24 and indicated Resident #2's Lorazepam consent
was unable to be located and recommended staff to obtain and scan consent into the chart.
During an interview on 09/19/24 at 1:23 p.m., the NP stated consents must be signed by residents' POAs .
During an interview on 09/19/24 at 2:39 p.m., the ADON stated her expectations for psychological consents
were that they were to be signed right away from pen to paper. The ADON stated consents must be signed
by the resident or the resident's RP. The ADON stated it was important to have consents signed so staff
had consent to treat the resident using medications. The ADON stated the receiving
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675956
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675956
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/19/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Windsor Nursing and Rehabilitation Center of Duval
5301 W Duval Rd
Austin, TX 78727
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
nurse was responsible for getting residents' consents signed. The ADON stated her, and the DON's job
were to oversee and make sure residents' consents were completed .
Review of the facility's Notification of Changes policy and procedure, implemented 10/24/22, reflected the
following:
Residents Affected - Few
The facility must inform the resident, consult with the resident's physician and /or notify the resident's family
member or legal representative when there is a change requiring such notification.
Circumstances requiring notification include:
3. Circumstances that require a need to alter treatment.
This may include:
a. New treatment.
Additional considerations:
2. Residents incapable of making decisions:
a. The representative would make any decisions that have to be made.
b. The resident should still be told what is happening go him or her.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675956
If continuation sheet
Page 3 of 3